Evidence map›Paper›PMID 35586746›Full record

Observational studyGlobal heart2022

Incidence, Predictors, and Outcomes of Acute and Sub-acute Stent Thrombosis after Emergency Percutaneous Coronary Revascularization with Drug-Eluting Stents: A Prospective Observational Study.

Rajesh Kumar, Ali Ammar, Tahir Saghir, Jawaid Akbar Sial, Jehangir Ali Shah, Ashok Kumar, Abdul Hakeem Shaikh, Abdul Samad Achakzai, Nadeem Qamar, Musa Karim

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in Global heart, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06667349 (Ticagrelor Intervention to Suppress Stent Thrombosis and Acute MI Risk), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06667349 phase4completednot on this mapstarted 2023, after this paper: background citation

Ticagrelor Intervention to Suppress Stent Thrombosis and Acute MI Risk (TISSARA) Trial: An LMIC Health System Initiative in the World's Busiest Primary PCI Center

TypeinterventionalSponsorNational Institute of Cardiovascular Diseases, PakistanRan2023 to 2024Enrolled1,727ConditionsSTEMI - ST Elevation Myocardial Infarction, Stent Thrombosis, Antiplatelet AgentsArmsTicagrelor
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Observational
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. A nightmare of clopidogrel resistance in a resource-limited setting: case report of subacute stent thrombosis.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2023
    Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Rajesh KumarNational Institute of Cardiovascular Diseases (NICVD), Karachi, PK.ORCID 0000-0002-6580-7193
Ali AmmarNational Institute of Cardiovascular Diseases (NICVD), Karachi, PK.ORCID 0000-0001-6317-8285
Tahir SaghirNational Institute of Cardiovascular Diseases (NICVD), Karachi, PK.ORCID 0000-0002-3148-8964
Jawaid Akbar SialNational Institute of Cardiovascular Diseases (NICVD), Karachi, PK.ORCID 0000-0003-3700-127X
Jehangir Ali ShahNational Institute of Cardiovascular Diseases (NICVD), Karachi, PK.ORCID 0000-0003-3624-2418
Ashok KumarNational Institute of Cardiovascular Diseases (NICVD), Hyderabad, PK.ORCID 0000-0002-0399-6507
Abdul Hakeem ShaikhNational Institute of Cardiovascular Diseases (NICVD), Karachi, PK.ORCID 0000-0001-8762-5991
Abdul Samad AchakzaiNational Institute of Cardiovascular Diseases (NICVD), Karachi, PK.ORCID 0000-0002-0248-506X
Nadeem QamarNational Institute of Cardiovascular Diseases (NICVD), Karachi, PK.ORCID 0000-0002-9379-1475
Musa KarimNational Institute of Cardiovascular Diseases (NICVD), Karachi, PK.ORCID 0000-0001-7941-8191
National Institute of Cardiovascular Diseases · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Stent thrombosis (ST) remains the most feared complication of percutaneous coronary intervention (PCI). Therefore, this study aimed to determine acute and sub-acute ST incidence, predictors, and outcomes after primary PCI. Methods: This prospective observational study included patients who had undergone primary PCI at a tertiary care cardiac center. All the patients were followed at 30-days of index hospitalization for the incidence of acute or sub-acute ST. ST was further categorized as definite, probable, or possible per the Academic Research Consortium definition. All the survivors of ST were followed after 6-months for the incidence of major adverse cardiovascular events. Results: An aggregate of 1756 patients were included with 79% (1388) male patients and mean age was 55.59 ± 11.23 years. The incidence of ST was 4.9% (86) with 1.3% (22) acute and 3.6% (64) sub-acute. ST was categorized as definite in 3.3% (58) and probable in 1.6% (28). Independent predictor of ST were observed to be male gender (odds ratio (OR); 2.51 [1.21-5.2]), left ventricular end-diastolic pressure ≥20 mmHg (OR; 2.55 [1.31-4.98]), and pre-procedure thrombolysis in myocardial infarction (TIMI) flow 0 (OR; 3.27 [1.61-6.65]). Cumulative all-cause mortality among patients with ST after 164.1 ± 76.2 days was 46.5% (40/86). Conclusion: We observed a substantial number of patients vulnerable to the acute or sub-acute ST after primary PCI. Male gender, LVEDP, pre-procedure TIMI flow grade can be used to identify and efficiently manage highly vulnerable patients.

Indexed as

Drug-Eluting StentsPercutaneous Coronary InterventionThrombosisAdultAgedHumansIncidenceMaleMiddle AgedTreatment OutcomeacuteDESMACEprimary PCISTEMIstent thrombosissub-acute

Identifiers

PMID35586746
PMCPMC8973861
OpenAlexW4226105180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.